-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MKJG5Rt5cEthgHRidPmp+af/oJcZwo9o2SBbMWEeWwpBpPUmcjTYtlzkZqyqWdS3 9ZzJ+N78VV+tfVTFKJ+1lA== 0001470274-09-000001.txt : 20090813 0001470274-09-000001.hdr.sgml : 20090813 20090812175538 ACCESSION NUMBER: 0001470274-09-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090813 DATE AS OF CHANGE: 20090812 EFFECTIVENESS DATE: 20090813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: On Demand Therapeutics, Inc. CENTRAL INDEX KEY: 0001470274 IRS NUMBER: 263425852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-133596 FILM NUMBER: 091007945 BUSINESS ADDRESS: STREET 1: 3520 WEST BAYSHORE RD. CITY: PALO ALTO STATE: CA ZIP: 94303 BUSINESS PHONE: (650) 854-8585 MAIL ADDRESS: STREET 1: 3520 WEST BAYSHORE RD. CITY: PALO ALTO STATE: CA ZIP: 94303 D 1 primary_doc.xml X0502 D LIVE 0001470274 On Demand Therapeutics, Inc. 3520 WEST BAYSHORE RD. PALO ALTO CA 94303 (650) 854-8585 None DELAWARE Corporation true 2008 Charline Gauthier c/o On Demand Therapeutics, Inc. 3520 West Bayshore Road Palo Alto CA 94303 Promoter John Santini c/o MicroCHIPS, Inc. 6-B Preston Court Bedford MA 01730 Director Gil Kliman c/o InterWest Partners X, L.P. 2710 Sand Hill Road, 2nd Floor Menlo Park CA 94025 Director Naveed Shams c/o On Demand Therapeutics, Inc. 3520 West Bayshore Road Palo Alto CA 94303 Executive Officer Gordon Saul c/o On Demand Therapeutics, Inc. 3520 West Bayshore Road Palo Alto CA 94303 Executive Officer Promoter Dave Weber c/o On Demand Therapeutics, Inc. 3520 West Bayshore Road Palo Alto CA 94303 Director Biotechnology Decline to Disclose 06 false 2009-05-08 false true true Common Stock and Series A Preferred Stock and the underlying Common Stock issued upon conversion of such Preferred Stock. false 0 1580000 830000 750000 false 2 0 0 0 false On Demand Therapeutics, Inc. /s/ Naveed Shams Naveed Shams President and CEO 2009-07-22 -----END PRIVACY-ENHANCED MESSAGE-----